In vitro comparison of novel polyurethane aortic valves and homografts after seeding and conditioning

ASAIO Journal

Volumn 59, Issue 3, 2013, Pages 309-316

  Thierfelder, Nikolaus ^a   Koenig, Fabian ^a,b   Bombien, René ^a   Fano, Cornelia ^c   Reichart, Bruno ^a   Wintermantel, Erich ^b   Schmitz, Christoph ^a   Akra, Bassil ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Institute of Textile Technologies and Process Engineering   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

bioreactor; cell conditioning; heart valve; homograft; synthetic scaffold; tissue engineering

Indexed keywords

EXTRACELLULAR MATRICES; HEART VALVES; HOMOGRAFT; IMMUNOHISTOCHEMICAL ANALYSIS; INFLAMMATORY GENE EXPRESSIONS; INFLAMMATORY RESPONSE; REAL-TIME POLYMERASE CHAIN REACTION; SYNTHETIC SCAFFOLDS;

BIOCOMPATIBILITY; BIOCONVERSION; BIOREACTORS; BLOOD VESSELS; CELL CULTURE; ENDOTHELIAL CELLS; GENE EXPRESSION; MOLECULAR WEIGHT; POLYMERASE CHAIN REACTION; POLYURETHANES; SCANNING ELECTRON MICROSCOPY; TISSUE; TISSUE ENGINEERING;

SCAFFOLDS (BIOLOGY);

POLYURETHAN;

ALLOGRAFT; AORTA GRAFT; AORTA VALVE; ARTICLE; BIOCOMPATIBILITY; BIOREACTOR; COMPARATIVE STUDY; CONDITIONING; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; INFLAMMATORY CELL; SCANNING ELECTRON MICROSCOPY; SHEAR STRESS;

AORTIC VALVE; BIOREACTORS; CELLS, CULTURED; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; FIBROBLASTS; HEART VALVE PROSTHESIS; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON, SCANNING; MIDDLE AGED; POLYURETHANES; PROSTHESIS DESIGN; REAL-TIME POLYMERASE CHAIN REACTION; TISSUE ENGINEERING; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 84877763724     PISSN: 10582916     EISSN: 1538943X     Source Type: Journal    
DOI: 10.1097/MAT.0b013e318289b95e     Document Type: Article

References (36)

1. Yacoub MH, Takkenberg JJ: Will heart valve tissue engineering change the world? Nat Clin Pract Cardiovasc Med 2: 60-61, 2005.
2. De Campos NL, de Andrade RR, Silva MA: Oral anticoagulation in carriers of mechanical heart valve prostheses: experience of ten years. Rev Bras Cir Cardiovasc 25: 457-465, 2010.
3. Hoffmann G, Lutter G, Cremer J: Durability of bioprosthetic cardiac valves. Dtsch Arztebl Int 105: 143-148, 2008.
4. Mendelson K, Schoen FJ: Heart valve tissue engineering: concepts, approaches, progress, and challenges. Ann Biomed Eng 34: 1799-1819, 2006.
5. Langer R, Vacanti JP: Tissue engineering. Science 260: 920-926, 1993.
6. Sodian R, Hoerstrup SP, Sperling JS, et al: Early in vivo experience with tissue-engineered trileafet heart valves. Circulation 102(19 suppl 3): iii22-iii29, 2000.
7. Lichtenberg A, Cebotari S, Tudorache I, Hilfker A, Haverich A: Biological scaffolds for heart valve tissue engineering. Methods Mol Med 140: 309-317, 2007.
8. Gulbins H, Dauner M, Petzold R, et al: Development of an artifcial vessel lined with human vascular cells. J Thorac Cardiovasc Surg 128: 372-377, 2004.
9. Gulbins H, Pritisanac A, Uhlig A, et al: Seeding of human endothelial cells on valve containing aortic mini-roots: development of a seeding device and procedure. Ann Thorac Surg 79: 2119-2126, 2005.
10. Gulbins H, Goldemund A, Anderson I, et al: Preseeding with autologous fbroblasts improves endothelialization of glutaral-dehyde-fxed porcine aortic valves. J Thorac Cardiovasc Surg 125: 592-601, 2003.
11. Koenig F, Hollweck T, Pfeifer S: A pulsatile bioreactor for conditioning of tissue-engineered cardiovascular constructs under endoscopic visualization. J. Funct. Biomater. 3, 480-496, 2012.
12. Yacoub MH, Cohn LH: Novel approaches to cardiac valve repair: From structure to function: Part I. Circulation 109: 942-950, 2004.
13. Butcher JT, Penrod AM, García AJ, Nerem RM: Unique morphology and focal adhesion development of valvular endothelial cells in static and fuid fow environments. Arterioscler Thromb Vasc Biol 24: 1429-1434, 2004.
14. Schaefermeier PK, Cabeza N, Besser JC, et al: Potential cell sources for tissue engineering of heart valves in comparison with human pulmonary valve cells. ASAIO J 55: 86-92, 2009.
15. Schnell AM, Hoerstrup S P, Zund G, et al: Optimal cell source for cardiovascular tissue engineering: venous vs. aortic human myofbroblasts. Thorac Cardiovasc Surg 49: 221-225, 2001.
16. Schmidt D, Hoerstrup SP: Tissue engineered heart valves based on human cells. Swiss Med Wkly 136: 618-623, 2006.
17. Zdrahala RJ, Zdrahala IJ: Biomedical applications of polyurethanes: A review of past promises, present realities, and a vibrant future. J Biomater Appl 14: 67-90, 1999.
18. Szycher M: Biostability of polyurethane elastomers: A critical review. J Biomater Appl 3: 297-402, 1988.
19. Kim MS, Kim JH, Min BH: Polymeric scaffolds for regenerative medicine. Polymer Reviews 51: 23-52, 2011.
20. Weston MW, LaBorde DV, Yoganathan AP: Estimation of the shear stress on the surface of an aortic valve leafet. Ann Biomed Eng 27: 572-579, 1999.
21. Balachandran K, Sucosky P, Yoganathan AP: Hemodynamics and mechanobiology of aortic valve infammation and calcifcation. Int J Infam 2011: 263870, 2011.
22. da Costa FD, Costa AC, Prestes R, et al: The early and midterm function of decellularized aortic valve allografts. Ann Thorac Surg 90: 1854-1860, 2010.
23. Baraki H, Tudorache I, Braun M, et al: Orthotopic replacement of the aortic valve with decellularized allograft in a sheep model. Biomaterials 30: 6240-6246, 2009.
24. Akhyari P, Kamiya H, Gwanmesia P, et al: In vivo functional performance and structural maturation of decellularised allogenic aortic valves in the subcoronary position. Eur J Cardiothorac Surg 38: 539-546, 2010.
25. Delmo Walter EM, de By TMMH, Meyer R, Hetzer R: The future of heart valve banking and of homografts: perspective from the Deutsches Herzzentrum Berlin. HSR Proceedings in Intensive Care and Cardiovascular Anesthesia 4: 97-108, 2012.
26. Filová E, Straka F, Mirejovský T, Masín J, Bacáková L: Tissueengineered heart valves. Physiol Res 58 suppl 2: S141-S158, 2009.
27. Lupinetti FM, Tsai TT, Kneebone JM, Bove EL: Effect of cryopreservation on the presence of endothelial cells on human valve allografts. J Thorac Cardiovasc Surg 106: 912-917, 1993.
28. Van Snick J: Interleukin-6: an overview. Annu Rev Immunol 8: 253-278, 1990.
29. Mukaida N, Harada A, Matsushima K: Interleukin-8 (iL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in infammatory and immune reactions. Cytokine Growth Factor Rev 9: 9-23, 1998.
30. Simionescu A, Schulte JB, Fercana G, Simionescu DT: Infammation in cardiovascular tissue engineering: the challenge to a promise: a minireview. Int J Infam 2011: 958247, 2011.
31. Li A, Dubey S, Varney ML, Dave BJ, Singh RK: IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 170: 3369-3376, 2003.
32. Heidemann J, Ogawa H, Dwinell MB, et al: Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endo-thelial cells are mediated by CXCr2. J Biol Chem 278: 8508-8515, 2003.
33. Bosman FT, Stamenkovic I: Functional structure and composition of the extracellular matrix. J Pathol 200: 423-428, 2003.
34. Jockenhoevel S, Zund G, Hoerstrup SP, Schnell A, Turina M: Cardiovascular tissue engineering: a new laminar fow chamber for in vitro improvement of mechanical tissue properties. ASAIO J 48: 8-11, 2002.
35. Sierad LN, Simionescu A, Albers C, et al: Design and testing of a pulsatile conditioning system for dynamic endothelializa-tion of polyphenol-stabilized tissue engineered heart valves. Cardiovasc Eng Technol 1: 138-153, 2010.
36. Szmitko PE, Wang CH, Weisel RD, de Almeida JR, Anderson TJ, Verma S: New markers of infammation and endothelial cell activation. Circulation 108: 1917-1923, 2002.